Rockwell Medical Technologies (RMTI) Misses Q4 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $8.05 -0.49%
Revenue Growth %: +14.9%
Financial Fact:
Operating Income (Loss): -4.75M
Today's EPS Names:
COHR, ATS, SICP, More
Revenue Growth %: +14.9%
Financial Fact:
Operating Income (Loss): -4.75M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Rockwell Medical Technologies (NASDAQ: RMTI) reported Q4 EPS of ($0.12), $0.14 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $14.1 million versus the consensus estimate of $19.98 million.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eversource Energy (ES) Tops Q3 EPS by 18c; offers guidance
- Suncor Energy (SU) Tops Q3 EPS by 172c
- Arcutis Biotherapeutics, Inc. (ARQT) Misses Q3 EPS by 12c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
